Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» prostate cancer
prostate cancer
Is BioSante Giving Away the Store?
Motley Fool
Wed, 04/20/11 - 09:55 am
BioSante
Aduro BioTech
pancreatic cancer
prostate cancer
Dendreon's Price Run May Be in Anticipation of Stronger Earnings
Seeking Alpha
Wed, 04/20/11 - 09:54 am
Dendreon
Provenge
prostate cancer
Exelixis spurs takeover rumors with Goldman ploy
Fierce Biotech
Tue, 04/12/11 - 10:17 am
prostate cancer
Exelixis
cabozantinib
Why Provenge Could Be a $10 Billion Drug for Dendreon
Seeking Alpha
Mon, 04/11/11 - 11:44 am
Provenge
prostate cancer
Dendreon
vaccines
Medivation Shares Popped: What You Need to Know
Motley Fool
Sat, 04/2/11 - 10:17 am
Medivation
MDV3100
prostate cancer
Medicare to pay for $93,000 prostate cancer drug Provenge
Yahoo/AP
Thu, 03/31/11 - 09:58 am
Medicare
prostate cancer
Dendreon
Provenge
Bristol-Myers' Yervoy and Dendreon's Provenge: Similarities Between First Two Active Immunotherapies in Cancer
Minyanville
Wed, 03/30/11 - 11:24 am
Yervoy
Provenge
Dendreon
Bristol-Myers Squibb
melanoma
prostate cancer
CMS Draft Guidance on Dendreon's Provenge Could Be Imminent
Seeking Alpha
Wed, 03/30/11 - 09:41 am
Dendreon
Provenge
prostate cancer
vaccines
CMS
GSK will no longer seek approval for dutasteride (Avodart) to prevent prostate cancer
LA Times, CA
Thu, 03/24/11 - 04:46 pm
prostate cancer
Avodart
GSK
GSK won’t pursue Avodart for prostate cancer
Bizjournals.com
Thu, 03/24/11 - 09:18 am
prostate cancer
GSK
Avodart
Comparing Medivation, Inc.'s and Johnson & Johnson's Prostate Cancer Drugs
Seeking Alpha
Mon, 03/21/11 - 02:56 pm
prostate cancer
Medivation
JNJ
Pfizer
Astellas
MDV3100
abiraterone
Five Prostate Cancer Diagnostics to Watch
Fierce Biomarkers
Wed, 03/16/11 - 10:54 am
prostate cancer
diagnostics
Myriad Genetics
Genomic Health
Oxford Gene Technology
Quanterix
Metamark Genetics
Study: Statins may reduce prostate cancer risk
Fierce Pharma
Tue, 03/15/11 - 11:09 am
prostate cancer
statins
Dendreon wins FDA nod on production increase
Fierce Pharma
Fri, 03/11/11 - 09:41 am
FDA
Dendreon
Provenge
vaccines
prostate cancer
When Will Dendreon Make Money?
Motley Fool
Thu, 03/3/11 - 07:57 am
Dendreon
vaccines
prostate cancer
Provenge
Key Questions For Dendreon
Forbes
Wed, 03/2/11 - 10:32 am
Dendreon
Provenge
vaccines
prostate cancer
Exelixis: Going Where No Drug Has Gone Before
Seeking Alpha
Wed, 02/23/11 - 10:47 pm
Exelixis
cabozantinib
prostate cancer
Dendreon: The Big Push on Provenge Begins
Seeking Alpha
Tue, 02/22/11 - 12:54 pm
Provenge
Dendreon
vaccines
prostate cancer
Why The New Dendreon Analysis Does Matter — And Why It Doesn’t
Forbes
Sat, 02/19/11 - 11:39 am
Provenge
prostate cancer
Dendreon
Exelixis shares rise after report on cancer drug
Yahoo/AP
Sat, 02/19/11 - 11:38 am
Exelixis
prostate cancer
cabozantinib
Pages
« first
‹ previous
…
20
21
22
23
24
25
26
27
28
…
next ›
last »